Ophiopojaponin C has shown significant potential in pharmacological research due to its bioactive properties. It exhibits anti-inflammatory and neuroprotective effects, making it a candidate for development in treating neurological disorders such as Alzheimer’s and Parkinson’s diseases. Studies indicate it may inhibit pathways involved in oxidative stress and neuronal damage. Additionally, it demonstrates antitumor activity by inducing apoptosis in certain cancer cell lines, particularly in liver and breast cancer models. Its ability to modulate immune responses also suggests possible use in autoimmune disease therapy. Research is ongoing to evaluate its bioavailability and efficacy in preclinical models.